| 1.51 -0.195 (-11.44%) | 01-21 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 2.51 |
1-year : | 3.01 |
| Resists | First : | 2.15 |
Second : | 2.57 |
| Pivot price | 1.92 |
|||
| Supports | First : | 1.46 |
Second : | 1.21 |
| MAs | MA(5) : | 1.78 |
MA(20) : | 1.87 |
| MA(100) : | 1.51 |
MA(250) : | 1.78 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 16.3 |
D(3) : | 24 |
| RSI | RSI(14): 40.9 |
|||
| 52-week | High : | 3.4 | Low : | 1.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CBUS ] has closed above bottom band by 5.6%. Bollinger Bands are 133% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.73 - 1.74 | 1.74 - 1.75 |
| Low: | 1.44 - 1.45 | 1.45 - 1.46 |
| Close: | 1.49 - 1.51 | 1.51 - 1.53 |
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
Sat, 17 Jan 2026
Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 32.4% in December - MarketBeat
Tue, 13 Jan 2026
Cibus' Agri-Bio Gamble - Technology Is Promising, Cash Is Limited, Execution Is Key - Seeking Alpha
Tue, 06 Jan 2026
Cibus And Interoc Sign LOI To Advance Herbicide-Tolerant Rice Commercialization In Latin America - iGrow News
Mon, 05 Jan 2026
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance
Sun, 04 Jan 2026
Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st
Mon, 08 Dec 2025
Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 53 (M) |
| Held by Insiders | 3.665e+007 (%) |
| Held by Institutions | 33.4 (%) |
| Shares Short | 1,220 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.575e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 510.2 % |
| Return on Equity (ttm) | -12.9 % |
| Qtrly Rev. Growth | 3.79e+006 % |
| Gross Profit (p.s.) | -40.2 |
| Sales Per Share | -92.88 |
| EBITDA (p.s.) | 2.41401e+006 |
| Qtrly Earnings Growth | -2.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -51 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 2.46 |
| Dividend | 0 |
| Forward Dividend | 1.08e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |